Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)
Clinical trial NCT04636333 · UNKNOWN
Trial details
- NCT number
- NCT04636333
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2021-12-07
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.